Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway
PLOS One · 04.08.2026 · 21 (8) · e0355259
DOI: 10.1371/journal.pone.0355259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 04.08.2026. Verfasst von PLOS One Editors. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Following the publication of this article [1], concerns were raised about Figs 2, 8, 10, and the welfare of the rats used in [1].
Zitieren
APA
PLOS One Editors (2026). Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway. PLOS One, 21(8), e0355259. https://doi.org/10.1371/journal.pone.0355259
Vancouver
PLOS One Editors. Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway. PLOS One. 2026;21(8):e0355259. doi:10.1371/journal.pone.0355259
BibTeX
@article{PLOSOneEditors2026,
author = {PLOS One Editors, PLOS One Editors},
title = {Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {8},
pages = {e0355259},
doi = {10.1371/journal.pone.0355259}
}
EUVIMED